investment

Antidepressant Drugmaker Seaport Seeks $212.4 Million in US IPO

Bloomberg

1 min read

0 likes

Antidepressant Drugmaker Seaport Seeks $212.4 Million in US IPO

Summarize this article with:

Seaport Therapeutics Inc., a clinical-stage biotechnology company focused on antidepressants and anxiety drugs, is seeking to raise $212.4 million in a US initial public offering.

Read Original

Source Information

Source: Bloomberg

Website: https://feeds.bloomberg.com/markets/news.rss

Antidepressant Drugmaker Seaport Seeks $212.4 Million in US IPO

Tags

Source Information